MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CLDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Celldex Therapeutics (CLDX) Ownership - Who owns Celldex Therapeutics?

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
53 Frontage Road
Phone
+1 908 200-7500
Employees
198
Web
https://www.celldex.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.45B
P/E Ratio
N/A
Total Cash
451.46M
Projected Growth
N/A
Total Debt
1.91M
Revenue
865K
Risk (Beta)
1.55
Dividend Yield
N/A
Total Cash/Share
5.75
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CLDX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for CLDX
A.I. Advisor
published General Information

General Information

a developer of immunotherapy technologies for the treatment of cancer and other diseases

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
53 Frontage Road
Phone
+1 908 200-7500
Employees
198
Web
https://www.celldex.com